| dc.creator | Xiromerisiou G., Kalampokini S., Rikos D., Provatas A., Tsouris Z., Markou K., Ralli S., Dardiotis E. | en |
| dc.date.accessioned | 2023-01-31T11:37:42Z | |
| dc.date.available | 2023-01-31T11:37:42Z | |
| dc.date.issued | 2020 | |
| dc.identifier | 10.1016/j.clineuro.2020.106037 | |
| dc.identifier.issn | 03038467 | |
| dc.identifier.uri | http://hdl.handle.net/11615/80855 | |
| dc.description.abstract | Guillain-Barre syndrome (GBS) is the most common cause of acute flaccid paralysis and its incidence increases with age, although all age groups can be affected. The cranial subtypes of GBS account for approximately 5% of cases. Posterior reversible encephalopathy syndrome (PRES) is an acute neurological disorder, mostly reversible but with increased morbidity with permanent neurological sequelae in severe cases. The coexistence of these two syndromes is very rare and underdiagnosed. To the best of our knowledge, there are several dozen cases reported in the literature including ours with the coexistence of these two syndromes in adult patients. We present a rare case of oculopharyngeal type of GBS followed by PRES syndrome. Based on the reviewed cases we discuss various pathogenic mechanisms that support the association between these two entities. This review illustrates the importance of detecting PRES syndrome in the context of acute inflammatory immune-mediated polyneuropathies especially when the patients present early dysautonomia. We also discuss the importance of early administration of immunoglobulin (IVIG) treatment but the possible risks that poses to the occurrence of PRES syndrome as well. © 2020 Elsevier B.V. | en |
| dc.language.iso | en | en |
| dc.source | Clinical Neurology and Neurosurgery | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087136794&doi=10.1016%2fj.clineuro.2020.106037&partnerID=40&md5=da45e501bd4b1f534c1c402fb527ab39 | |
| dc.subject | ganglioside antibody | en |
| dc.subject | ganglioside GD 1a | en |
| dc.subject | ganglioside GD 1b | en |
| dc.subject | ganglioside GD3 | en |
| dc.subject | ganglioside GM1 antibody | en |
| dc.subject | ganglioside GM1b antibody | en |
| dc.subject | ganglioside GM2 antibody | en |
| dc.subject | ganglioside GQ 1b antibody | en |
| dc.subject | ganglioside GT 1a | en |
| dc.subject | ganglioside GT 1b | en |
| dc.subject | immunoglobulin | en |
| dc.subject | immunoglobulin G antibody | en |
| dc.subject | immunoglobulin M antibody | en |
| dc.subject | labetalol | en |
| dc.subject | nitroprusside sodium | en |
| dc.subject | sulfatide | en |
| dc.subject | unclassified drug | en |
| dc.subject | ganglioside | en |
| dc.subject | immunoglobulin | en |
| dc.subject | adult | en |
| dc.subject | case report | en |
| dc.subject | cerebrospinal fluid analysis | en |
| dc.subject | clinical article | en |
| dc.subject | computer assisted tomography | en |
| dc.subject | confusion | en |
| dc.subject | diplopia | en |
| dc.subject | dysarthria | en |
| dc.subject | dysautonomia | en |
| dc.subject | dysphagia | en |
| dc.subject | female | en |
| dc.subject | follow up | en |
| dc.subject | Guillain Barre syndrome | en |
| dc.subject | hallucination | en |
| dc.subject | headache | en |
| dc.subject | human | en |
| dc.subject | hypertension | en |
| dc.subject | malignant hypertension | en |
| dc.subject | neuroimaging | en |
| dc.subject | neurologic examination | en |
| dc.subject | oculopharyngeal variant of Guillain Barre syndrome | en |
| dc.subject | orthostatic hypotension | en |
| dc.subject | posterior reversible encephalopathy syndrome | en |
| dc.subject | ptosis (eyelid) | en |
| dc.subject | Review | en |
| dc.subject | thin layer chromatography | en |
| dc.subject | tongue | en |
| dc.subject | weakness | en |
| dc.subject | complication | en |
| dc.subject | dysautonomia | en |
| dc.subject | Guillain Barre syndrome | en |
| dc.subject | immunology | en |
| dc.subject | posterior reversible encephalopathy syndrome | en |
| dc.subject | Adult | en |
| dc.subject | Female | en |
| dc.subject | Gangliosides | en |
| dc.subject | Guillain-Barre Syndrome | en |
| dc.subject | Humans | en |
| dc.subject | Immunoglobulins, Intravenous | en |
| dc.subject | Posterior Leukoencephalopathy Syndrome | en |
| dc.subject | Primary Dysautonomias | en |
| dc.subject | Elsevier B.V. | en |
| dc.title | Posterior reversible encephalopathy in a GT1a positive oculopharyngeal variant of Guillain-Barré syndrome: A case-report and review of the literature | en |
| dc.type | other | en |